Stryker Corporation Stock

Equities

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-06-10 pm EDT 5-day change 1st Jan Change
348.2 USD -0.33% Intraday chart for Stryker Corporation +2.59% +16.27%
Sales 2024 * 22.3B Sales 2025 * 24B Capitalization 133B
Net income 2024 * 3.88B Net income 2025 * 4.45B EV / Sales 2024 * 6.29 x
Net Debt 2024 * 7.26B Net Debt 2025 * 4.47B EV / Sales 2025 * 5.73 x
P/E ratio 2024 *
34.1 x
P/E ratio 2025 *
29.8 x
Employees 52,000
Yield 2024 *
0.95%
Yield 2025 *
1.03%
Free-Float 94.61%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.09%
1 week+2.42%
Current month+2.42%
1 month+5.58%
3 months-2.39%
6 months+20.83%
Current year+16.65%
More quotes
1 week
338.53
Extreme 338.53
351.56
1 month
322.50
Extreme 322.5
351.56
Current year
292.43
Extreme 292.43
361.41
1 year
249.98
Extreme 249.98
361.41
3 years
188.84
Extreme 188.84
361.41
5 years
124.54
Extreme 124.54
361.41
10 years
77.87
Extreme 77.87
361.41
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 11-04-24
Director of Finance/CFO 62 02-12-31
Chief Tech/Sci/R&D Officer - 14-12-31
Members of the board TitleAgeSince
Director/Board Member 80 73-12-31
Director/Board Member 65 18-05-01
Director/Board Member 89 77-01-31
More insiders
Date Price Change Volume
24-06-10 348.2 -0.33% 898 324
24-06-07 349.3 -0.09% 847,236
24-06-06 349.6 +1.05% 1,050,410
24-06-05 346 +1.17% 1,121,558
24-06-04 342 +0.77% 1,729,911

Delayed Quote Nyse, June 07, 2024 at 04:00 pm EDT

More quotes
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
349.3 USD
Average target price
373.1 USD
Spread / Average Target
+6.80%
Consensus